Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.325    -0.0025 (-0.76%)
Bid:
0.32
Ask:
0.33
Spread: 0.01 (3.125%)
Market Cap: £25.27m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Consulting Agreement

17 Jul 2014 07:00

HAYDALE GRAPHENE INDUSTRIES PLC - Consulting Agreement

HAYDALE GRAPHENE INDUSTRIES PLC - Consulting Agreement

PR Newswire

London, July 16

Haydale Graphene Industries plc ("Haydale" or the "Company") Consulting Agreement with The InVentures Group Haydale Graphene Industries plc (AIM:HAYD), the Company focused on enablingtechnology for the commercialisation of graphene and other nano materials, ispleased to announce a consulting agreement with New York based The InVenturesGroup ("InVentures") ("Agreement") to accelerate the commercial application ofits plasma functionalisation technology in graphene, carbon nanotubes and otherhigh performance nanomaterial systems. Pursuant to the terms of the Agreement, a retainer will be paid by Haydale overan initial 12 month period, during which time InVentures will promote Haydale'splasma functionalisation technology to potential R&D customers and commercialpartners in Haydale's target markets of inks and coatings, composites andenergy harvesting. Further, InVentures will identify and prioritise areas ofapplication for Haydale's plasma based functionalisation technology and seek toengage high profile organisations as potential strategic partners, customersand/or licensees. A warrant agreement has been signed between the Company and InVentures whichgrants InVentures up to 60,000 warrants to subscribe for ordinary shares of £0.02p each in the Company ("Ordinary Shares") at an exercise price of £1.60subject to the satisfaction of certain vesting conditions relating to therevenues generated by InVentures for the Company in the period to 30 June 2015.These warrants have an exercise period beginning on 1 July 2015 and ending on30 June 2018. The total number of options and warrants now outstanding over Ordinary Sharesis 1,021,215 representing 9.1% per cent. of the Company's ordinary issued sharecapital. Ray Gibbs, CEO at Haydale, commented: "Haydale's goal is to be the premiersolutions provider in enabling commercialisation of certain nano materials suchas graphenes. Our novel functionalisation process enables the nano particles tobe uniformly dispersed in a target material. In our view, dispersion is the keyto commercialising materials like graphenes and recent third party resultsdemonstrate that our technology works well. This Agreement will enable Haydaleto increase significantly its market presence in North America and Canada. Weexpect this Agreement to allow a greater number of potential R&D customers totest and analyse our plasma functionalised materials for integration into theirspecific products and applications." "We are excited to be working with the outstanding team at InVentures, most ofwhom have spent their careers developing, scaling, and commercialising advancedmaterials and understand the challenges and opportunities. Their reputation,relationships, and network of partners and customers combined with theirexperience in overcoming the hurdles that face companies introducing newmaterials into established markets is expected to serve Haydale well as we lookto expand the impact of our technology onto the global market." Keith Blakely, Chairman and CEO of InVentures, commented: "Graphene isunquestionably one of the most exciting material discoveries so far thiscentury and has astounding intrinsic properties including incredible strength,the highest thermal and electrical conductivity known, and othercharacteristics that have the potential to impact nearly every industry. We arevery excited to be working with Haydale to accelerate the process ofidentifying specifically in the North American and Canadian markets the mostpromising applications of their technology and materials in commercialapplications." - ends - For further information please contact: Haydale Graphene Industries plc 01269 842 946John Knowles, ChairmanRay Gibbs, Chief Executive Officer Cairn Financial Advisers LLP (Nomad) 0207 148 7900Tony RawlinsonPaul Trendell Cantor Fitzgerald Europe (Joint Broker) 020 7894 7000David ForemanPaul Jewell Hume Capital Securities plc (Joint Broker) 020 3693 1470Guy PetersDavid Lawman Hermes Financial PRTrevor Phillips 07889 153 628Chris Steele 07979 604 687 About Haydale Haydale has developed a patent pending proprietary scalable plasma process tofunctionalise graphene and other nanomaterials. This enabling technology canprovide Haydale with a rapid and highly cost efficient method of supplyingtailored solutions to enhance applications for both raw material suppliers andproduct manufacturers. Functionalisation is carried out through a low pressure plasma process thattreats both organic mined fine powder and other synthetically producednanomaterial powders producing high quality few layered graphenes and graphenenano platelets. The process can functionalise with a range of chemical groups,where the amount of chemicals can be tailored to the customer needs. Gooddispersion improves the properties and performance of the host material andensures it delivers as specified. The Haydale plasma process does not use wet chemistry, neither does it damagethe material being processed, rather it can clean up impurities inherent in theraw material. The technology is a low energy user and most importantlyenvironmentally friendly. The Haydale method is an enabling technology whereworking with a raw material producer can add value to the base product andtailor the outputs to meet the target applications of the end user. Haydale, based in South Wales, housed in a purpose built facility forprocessing and handling nanomaterials with a laboratory facility, isfacilitating the application of graphenes and other nanomaterials in fieldssuch as inks, sensors, energy storage, photovoltaics, composites, paints andcoatings. www.haydale.com About The InVentures Group The InVentures Group delivers strategic forward thinking and mentoring tostart-up and established companies. They specialise in high technologycompanies, products and services with an emphasis on assisting in the complexand highly challenging task of bringing new product ideas and technology tomarket. InVentures are specialists in bringing new technologies to the NorthAmerican market and instrumental in the formation of the Graphene StakeholdersAssociation (GSA) in 2012,

For more information, visit www.theinventuresgroup.com

Date   Source Headline
21st May 20267:05 amRNSProposed Commercial Relationship
8th Apr 20265:18 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSNew Contract Signed
26th Mar 20263:39 pmRNSResult of AGM
6th Mar 20261:31 pmRNSInvestor Presentation via Investor Meet Company
2nd Mar 20267:00 amRNSStrategic Digital Infrastructure Partnership
17th Feb 20267:00 amRNSFinal Results and Post-Period Trading Update
11th Feb 20267:00 amRNSNotice of Annual Results
30th Jan 20269:45 amRNSTotal Voting Rights
22nd Jan 20264:54 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSHolding(s) in Company
21st Jan 202612:31 pmRNSHolding(s) in Company
15th Jan 20265:01 pmRNSHolding(s) in Company
15th Jan 20262:44 pmRNSChange of Name
12th Jan 20267:00 amRNSCompletion of Acquisition
9th Jan 20266:19 pmRNSDirector/PDMR Dealings
8th Jan 20261:59 pmRNSHolding(s) in Company
8th Jan 20261:55 pmRNSHolding(s) in Company
6th Jan 20262:45 pmRNSResult of General Meeting and Total Voting Rights
22nd Dec 20252:08 pmRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSHolding(s) in Company
16th Dec 202512:45 pmRNSResult of Retail Offer
15th Dec 20259:14 amRNSResult of Accelerated Bookbuild
12th Dec 20257:05 amRNSRetail Offer
12th Dec 20257:00 amRNSProposed Fundraise and Acquisition
2nd Dec 20257:00 amRNSCommercial Update
30th Oct 202510:45 amRNSExpansion of Commercial Platform
23rd Oct 20257:00 amRNSContract Wins
11th Sep 20257:00 amRNSStrategic Collaboration and Trading Update
8th Aug 20257:00 amRNSGrant of Share Options and PDMR Dealings
11th Jul 20258:21 amRNSHolding(s) in Company
30th Jun 20253:14 pmRNSHolding(s) in Company
26th Jun 20252:00 pmRNSSubscriptions, Director Dealings & Issue of Equity
12th Jun 20252:12 pmRNSTrading Update
23rd Apr 20255:22 pmRNSDirectorate Change
17th Apr 202510:46 amRNSCorrection: Haydale US Sales Process Update
17th Apr 20257:00 amRNSHaydale US Sales Process Update
2nd Apr 20257:00 amRNSHaydale Achieves CE Certification
13th Mar 20252:15 pmRNSSubscription, Director Dealings and TVR
13th Mar 20257:00 amRNSInterim Results
7th Mar 202510:18 amRNSHaydale US sales process update
10th Feb 20257:00 amRNSHaydale US placed into insolvency process
30th Dec 20245:20 pmRNSReplacement: Result of AGM
30th Dec 202412:48 pmRNSResult of AGM
23rd Dec 20247:05 amRNSDisposal of Korean Subsidiary
23rd Dec 20247:00 amRNSBusiness Review and Appointment of CEO
6th Dec 20247:00 amRNSPosting of Annual Report and Notice of AGM
4th Dec 20249:44 amRNSHolding(s) in Company
3rd Dec 20245:38 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.